Grid › Hospital & Medical Service Plans

ELV Elevance Health, Inc.

NYSE, CIK 0001156039, fiscal year ends 12/31. Last price 439.95 on 2026-10-23, market value 95.1 billion dollars.

Machine-readable: ELV.json, ELV.md. Librarian dossier (cited facts, written 2026-10-16): ELV dossier. Sections: Graham Defensive, Magic Formula, Momentum, Insider, Buffett Quality, Lynch GARP, Graham Enterprising, Piotroski F-Score, earnings record, insiders, filings and links.

Philosophy	Score	Status	Current inputs as of	History used	Price	Verification	Rules
Graham Defensive	n/a	not scored (financial)	—	—	—	—	method
Magic Formula	n/a	not scored	—	—	—	—	method
Momentum	73	ok	2026-10-23	—	2026-10-23	—	method
Insider	0	ok	2026-10-23	—	—	—	method
Buffett Quality	n/a	not scored (financial)	—	—	—	—	method
Lynch GARP	n/a	not scored (financial)	—	—	—	—	method
Graham Enterprising	n/a	not scored (financial)	—	—	—	—	method
Piotroski F-Score	n/a	not scored (financial)	—	—	—	—	method

Market value, source trail

market_value = traded_price (price date) / depositary_ratio x latest point-in-time SEC shares outstanding (share-count date shown; from the filing cover page, summed across share classes only where the issuer filing verifies the classes are economically equivalent (rule + evidence URL in the source text), else withheld; priced at the primary listed class, so where other classes trade at a different price the value is an approximation; restated only for issuer-verified splits after the count date); weighted-average share counts are never used

Input	Value	Unit	Period / date	Source
Traded price	439.95	USD per traded unit (share or ADS)	2026-10-23	Yahoo Finance
SEC shares outstanding	216,055,891	underlying shares	2026-10-15	SEC cover page 10-Q 0001156039-26-000071 (216,055,891 shares (single class on cover)); filing document https://www.sec.gov/Archives/edgar/data/1156039/000115603926000071/elv-20260930.htm 0001156039-26-000071
Depositary ratio	1.0	underlying shares per traded unit		domestic 10-K filer; SEC shares are the traded units
Market value price date × latest reported shares	95,053,789,245	USD	2026-10-23 shares at 2026-10-15	439.95 (price 2026-10-23) / 1 x 216,055,891 (shares at 2026-10-15) = 95,053,789,245

Graham Defensive

not scored (financial). How this is scored.

not scored (financial).

Magic Formula

not scored. How this is scored.

not scored.

Momentum

73 of 100. ok. How this is scored.

Test or factor	Value	Points
12-1 month return	17.4 % (percentile 63.9)	32.0 / 50
6 month return	28.1 % (percentile 86.5)	17.3 / 20
Price / 52-week high	0.988	14.8 / 15
Volatility penalty (60d annualised)	24.5 %	9.3 / 15

Inputs, 1 numbers with their sources

Input	Value	Period	Source	Check
Adjusted close series (14 months)	439.95	2026-10-23	Yahoo Finance / Alpaca Market Data daily history	not cross-checked

Insider

0 of 100. ok. How this is scored. Form 4 data loaded through 2026-10-23

Test or factor	Value	Points
Open-market buy value / market cap (percentile among buyers)	0.0 bp	0.0 / 35
Distinct buyers	0	0.0 / 25
Buyer seniority	0.0	0.0 / 20
Recency (half-life 30d)	0.0	0.0 / 10
Sales penalty (excludes 10b5-1 plan sales)	0.49 bp	-5.6 / 0

Inputs, 13 numbers with their sources

Input	Value	Period	Source	Check
Form 4 S Kaye Mark 2026-10-22	122082.87	2026-10-22	SEC Form 4 (insider transactions data set)	not cross-checked
Form 4 S Kaye Mark 2026-10-22	368883.35000000003	2026-10-22	SEC Form 4 (insider transactions data set)	not cross-checked
Form 4 S Kaye Mark 2026-10-22	71176.0	2026-10-22	SEC Form 4 (insider transactions data set)	not cross-checked
Form 4 S Kaye Mark 2026-10-22	195276.4	2026-10-22	SEC Form 4 (insider transactions data set)	not cross-checked
Form 4 S Kaye Mark 2026-10-22	212452.80000000002	2026-10-22	SEC Form 4 (insider transactions data set)	not cross-checked
Form 4 S Kaye Mark 2026-10-22	1034059.62	2026-10-22	SEC Form 4 (insider transactions data set)	not cross-checked
Form 4 S Kaye Mark 2026-10-22	757556.8	2026-10-22	SEC Form 4 (insider transactions data set)	not cross-checked
Form 4 S Kaye Mark 2026-10-22	509530.0	2026-10-22	SEC Form 4 (insider transactions data set)	not cross-checked
Form 4 S Kaye Mark 2026-10-22	105172.8	2026-10-22	SEC Form 4 (insider transactions data set)	not cross-checked
Form 4 S Kaye Mark 2026-10-22	244759.19999999998	2026-10-22	SEC Form 4 (insider transactions data set)	not cross-checked
Form 4 S Kaye Mark 2026-10-22	724092.0	2026-10-22	SEC Form 4 (insider transactions data set)	not cross-checked
Form 4 S Kaye Mark 2026-10-22	139715.25	2026-10-22	SEC Form 4 (insider transactions data set)	not cross-checked
Form 4 S Kaye Mark 2026-10-22	173600.0	2026-10-22	SEC Form 4 (insider transactions data set)	not cross-checked

Buffett Quality

not scored (financial). How this is scored.

not scored (financial).

Lynch GARP

not scored (financial). How this is scored.

not scored (financial).

Graham Enterprising

not scored (financial). How this is scored.

not scored (financial).

Piotroski F-Score

not scored (financial). How this is scored.

not scored (financial).

Earnings record

SEC XBRL, by fiscal year (named by the calendar year it ends in); EPS split-adjusted to today's shares; each row links to the filing.

FY	Ended	Revenue, $M	Net income, $M	EPS diluted	Dividend	Filing
2013	2013-12-31	71,024	2,490	8.2	paid	0001156039-16-000018
2014	2014-12-31	73,874	2,570	8.99	paid	0001156039-17-000002
2015	2015-12-31	79,156	2,560	9.38	paid	0001156039-18-000003
2016	2016-12-31	84,863	2,470	9.21	paid	0001156039-19-000004
2017	2017-12-31	90,040	3,843	14.35	paid	0001156039-20-000003
2018	2018-12-31	92,105	3,750	14.19	paid	0001156039-21-000012
2019	2019-12-31	104,213	4,807	18.47	paid	0001156039-22-000009
2020	2020-12-31	121,867	4,572	17.98	paid	0001156039-23-000109
2021	2021-12-31	138,639	6,158	24.95	paid	0001156039-24-000015
2022	2022-12-31	156,595	5,894	24.28	paid	0001156039-25-000010
2023	2023-12-31	171,340	5,987	25.22	paid	0001156039-26-000013
2024	2024-12-31	177,011	5,980	25.68	paid	0001156039-26-000013
2025	2025-12-31	199,125	5,662	25.21	paid	0001156039-26-000013

Insider transactions

SEC Form 4 open-market purchases and sales from the insider data sets; latest 20.

Date	Insider	Role	Type	Shares	Price	Value
2026-10-22	Kaye Mark	CFO	sale	273	447.19	122,083
2026-10-22	Kaye Mark	CFO	sale	827	446.05	368,883
2026-10-22	Kaye Mark	CFO	sale	160	444.85	71,176
2026-10-22	Kaye Mark	CFO	sale	440	443.81	195,276
2026-10-22	Kaye Mark	CFO	sale	480	442.61	212,453
2026-10-22	Kaye Mark	CFO	sale	2,343	441.34	1,034,060
2026-10-22	Kaye Mark	CFO	sale	1,720	440.44	757,557
2026-10-22	Kaye Mark	CFO	sale	1,160	439.25	509,530
2026-10-22	Kaye Mark	CFO	sale	240	438.22	105,173
2026-10-22	Kaye Mark	CFO	sale	560	437.07	244,759
2026-10-22	Kaye Mark	CFO	sale	1,660	436.20	724,092
2026-10-22	Kaye Mark	CFO	sale	321	435.25	139,715
2026-10-22	Kaye Mark	CFO	sale	400	434.00	173,600
2026-07-17	Boudreaux Gail	CEO	buy	2,045	368.25	753,071
2026-07-17	Boudreaux Gail	CEO	buy	680	366.41	249,159
2026-07-17	Peru Ramiro G	director	buy	1,000	366.05	366,050
2026-06-12	Penczek Ronald W	officer	sale	369	403.16	148,766
2026-06-11	Dixon Robert L Jr	director	sale	151	401.77	60,667
2026-05-19	Penczek Ronald W	officer	sale	1,531	403.13	617,192

Filings and links

Third-party sites are linked only; nothing from them is stored here.

SEC: filing index, 8-K, Form 4, XBRL companyfacts
Prices: Yahoo Finance, Stooq
Elsewhere: morningstar, finviz, stockanalysis, seeking alpha, openinsider, google news

Cite as: The Claude Trader snapshot 2026-10-26, https://theclaudetrader.com/s/ELV; data from SEC EDGAR XBRL and market prices (Alpaca Market Data, Yahoo Finance) to 2026-10-23. Data last checked 2026-10-26.